Device type · IEO
Processor, Tissue, Automated
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
IEO
Pathology
Device class
Class I
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
59
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Processor, Tissue, Automated
- Product code
- IEO
- Device class
- Class I
- Review panel
- Pathology
- Regulation
- 21 CFR 864.3875
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for IEO
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
59
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
17
29% of reports
Injury reports
42
71% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 3 | 4 | 0 | 0 |
| Jan 24 | 2 | 0 | 0 | 0 |
| Feb 24 | 3 | 6 | 0 | 0 |
| Mar 24 | 6 | 5 | 0 | 0 |
| Apr 24 | 2 | 5 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 3 | 0 | 0 | 0 |
| Jul 24 | 5 | 2 | 0 | 0 |
| Aug 24 | 1 | 6 | 0 | 0 |
| Sep 24 | 2 | 2 | 0 | 0 |
| Oct 24 | 2 | 4 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 3 | 3 | 0 | 0 |
| Jan 25 | 1 | 1 | 0 | 0 |
| Feb 25 | 3 | 1 | 0 | 0 |
| Mar 25 | 4 | 3 | 0 | 0 |
| Apr 25 | 0 | 2 | 0 | 0 |
| May 25 | 3 | 6 | 0 | 0 |
| Jun 25 | 3 | 4 | 0 | 0 |
| Jul 25 | 0 | 9 | 0 | 0 |
| Aug 25 | 2 | 1 | 0 | 0 |
| Sep 25 | 1 | 2 | 0 | 0 |
| Oct 25 | 2 | 6 | 0 | 0 |
| Nov 25 | 0 | 2 | 0 | 0 |
| Dec 25 | 0 | 12 | 0 | 0 |
| Jan 26 | 3 | 0 | 0 | 0 |
| Feb 26 | 1 | 0 | 0 | 0 |
| Mar 26 | 1 | 2 | 0 | 0 |
| Apr 26 | 2 | 0 | 0 | 0 |
| May 26 | 0 | 2 | 0 | 0 |
| Jun 26 | 3 | 8 | 0 | 0 |
| Jul 26 | 2 | 2 | 0 | 0 |
| Aug 26 | 0 | 1 | 0 | 0 |
| Sep 26 | 3 | 5 | 0 | 0 |
| Oct 26 | 2 | 8 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
2 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Improper or Incorrect Procedure or Method32
- Use of Device Problem13
- Leak/Splash11
6 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Insufficient Information31
- No Clinical Signs, Symptoms or Conditions19
- Unspecified Tissue Injury12
1 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Leica Biosystems Melbourne Pty Ltd
Z-1683-2025 · Started Apr 2, 2025 · Posted by FDA Apr 28, 2025
Reason given: There is a leakage issue associated with the tubing in the manifold of the instrument.
Cause as FDA categorized it: Release of Material/Component prior to receiving test results
- Leica HistoCore PEGASUS Tissue Processor, REF 14048858005.Open, Classified
LEICA BIOSYSTEMS NUSSLOCH GMBH
Z-1947-2024 · Started Apr 10, 2024 · Posted by FDA Jun 4, 2024
Reason given: Poorly processed and/or damaged biopsy tissue specimens on the device resulting from reagent levels exceeding the maximum fill level marks on reagent bottles or in the paraffin tanks.
Cause as FDA categorized it: Device Design
- Leica HistoCore PEGASUS (PROCESSOR, TISSUE, AUTOMATED)Open, Classified
LEICA BIOSYSTEMS NUSSLOCH GMBH
Z-0590-2024 · Started Nov 20, 2023 · Posted by FDA Dec 20, 2023
Reason given: There is an issue regarding poorly processed and/or damaged biopsy tissue specimens on the HistoCore PEGASUS / HistoCore PEGASUS Plus resulting from an incorrect assignment of the carryover value set for created or edited protocols.
Cause as FDA categorized it: Other
8 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.